Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Japan Epigenetics Market
Chapter 4. Japan Epigenetics Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User
4.2. Industry Outlook
4.2.1. Advances in Epigenetic Technology
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2027
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2020
4.8.3. Competitor Mapping
Chapter 5. Japan Epigenetics Market, By Product Type
5.1. Key Insights
5.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
5.2.1. Reagents
5.2.2. Kits
5.2.2.1. Bisulfite Conversion Kits
5.2.2.2. ChIP Kits
5.2.2.3. RNA kits
5.2.2.4. Others
5.2.3. Instruments
5.2.4. Software Tools
5.2.4.1. EpiGRAPH
5.2.4.2. BiQ Analyzer
5.2.4.3. RnBeads
5.2.4.4. Others
5.2.5. Enzymes
5.2.6. Proteins & Peptides
5.2.7. Antibodies
5.2.8. Services
Chapter 6. Japan Epigenetics Market, By Technology
6.1. Key Insights
6.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
6.2.1. DNA Methylation
6.2.2. Histone Methylation
6.2.3. Histone Acetylation
6.2.4. Bromodomains
6.2.5. Non-Coding RNA
6.2.6. Others
Chapter 7. Japan Epigenetics Market, By Application
7.1. Key Insights
7.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
7.2.1. Oncology
7.2.2. Non-Oncology
7.2.2.1. Cardiovascular Diseases
7.2.2.2. Neurodegenerative
7.2.2.3. Autoimmune
Chapter 8. Japan Epigenetics Market, By End Users
8.1. Key Insights
8.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
8.2.1. Academic and Research Institutes
8.2.2. Pharmaceutical & Biotechnology Companies
8.2.3. Contract Research Organizations (CROs)
8.2.4. Research and consulting firms
Chapter 9. Company Profile (Company Overview, Financial Matrix, Sales Composition Ration, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
9.1. Epigeneron
9.2. National Institute of Genetics
9.3. Rhelixa Inc
9.4. Riken
9.5. Illumina, Inc.
9.6. Daiichi Sankyo Company, Limited
9.7. Takeda Pharmaceutical Co.
9.8. Abcam PLC